As part of its Breakthrough Devices Program, the FDA recently authorized marketing for the Brain Trauma Indicator, the first blood test to evaluate mild traumatic brain injury (TBI) in adults.
As part of its Breakthrough Devices Program, the FDA recently authorized marketing for the Brain Trauma Indicator, the first blood test to evaluate mild traumatic brain injury (TBI) in adults.